Panagora Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-140,847
| Closed | -$330K | – | 2566 |
|
|
2018
Q2 | $330K | Buy |
140,847
+2,139
| +2% | +$5.01K | ﹤0.01% | 1496 |
|
|
2018
Q1 | $408K | Buy |
138,708
+42,917
| +45% | +$126K | ﹤0.01% | 1452 |
|
|
2017
Q4 | $262K | Buy |
+95,791
| New | +$262K | ﹤0.01% | 1581 |
|
|
2017
Q3 | – | Sell |
-4,366
| Closed | -$11K | – | 2677 |
|
|
2017
Q2 | $11K | Sell |
4,366
-5,840
| -57% | -$14.7K | ﹤0.01% | 2379 |
|
|
2017
Q1 | $23K | Sell |
10,206
-335,807
| -97% | -$757K | ﹤0.01% | 2154 |
|
|
2016
Q4 | $734K | Buy |
+346,013
| New | +$734K | ﹤0.01% | 1320 |
|
|
2015
Q1 | – | Sell |
-82,829
| Closed | -$639K | – | 2476 |
|
|
2014
Q4 | $639K | Sell |
82,829
-143,875
| -63% | -$1.11M | ﹤0.01% | 1190 |
|
|
2014
Q3 | $1.69M | Sell |
226,704
-15,766
| -7% | -$118K | 0.01% | 816 |
|
|
2014
Q2 | $2.35M | Sell |
242,470
-355,019
| -59% | -$3.44M | 0.01% | 760 |
|
|
2014
Q1 | $4.97M | Buy |
597,489
+104,132
| +21% | +$865K | 0.02% | 550 |
|
|
2013
Q4 | $4.16M | Buy |
493,357
+40,283
| +9% | +$340K | 0.02% | 586 |
|
|
2013
Q3 | $3.61M | Sell |
453,074
-14,824
| -3% | -$118K | 0.02% | 607 |
|
|
2013
Q2 | $3.61M | Buy |
+467,898
| New | +$3.61M | 0.02% | 556 |
|